BB Biotech AG (BION)
SIX
Real-time Data
07:00 AM
Day's Range
54.9052 wk Range
31.90Overview - BION - BB Biotech AG
Key Statistics
Valuation
Enterprise Value
-15.46M
P/E (Trailing)
‪2.25‬
P/E (Forward)
‪-84.37‬
PEG Ratio
‪-0.0079‬
Price / Sales (TTM)
‪2.88‬
Price / Book
‪0.99‬
Profitability
Profit Margin
‪127.31%‬
Operating Margin
‪97.74%‬
Return on Assets
‪25.87%‬
Return on Equity
‪54.76%‬
Ownership
Shares Outstanding
55.14M
Held by Insiders
‪0.07%‬
Held by Institutions
‪19.24%‬
Price stats
Beta
‪0.65‬
50-Day Avg
‪50.27‬
200-Day Avg
‪46.52‬
Dividends
Payout Ratio
‪9.16%‬
Frequency
Annual
Analyst Consensus
2 analysts
Peers - BION - BB Biotech AG
Peer Comparison
Compared with companies in Biotechnology listed on SIX.
- BIONSIXBB Biotech AG3.08BMarket Cap+41.95%52-week change2.24P/E (Trailing)‪127.31%‬Profit Margin
- BSLNSIXBasilea Pharmaceutica Ltd811.90MMarket Cap+27.67%52-week change19.90P/E (Trailing)‪21.17%‬Profit Margin
- BIOVSIXBioVersys AG147.36MMarket Cap+2.78%52-week change-6.50P/E (Trailing)‪-386.62%‬Profit Margin
- ADXNSIXAddex Therapeutics Ltd6.28MMarket Cap-38.65%52-week change-0.67P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - BION - BB Biotech AG
About
BB Biotech AG is a Switzerland-based investment company specializing in the biotechnology sector. Founded in 1993 and headquartered in Schaffhausen, it invests primarily in publicly traded companies developing and commercializing innovative drugs that address significant unmet medical needs, such as oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
